This site is intended for healthcare professionals only

Vitamin D supplementation and chance of regression from prediabetes to normal glucose regulation

Vitamin D supplementation reduces risk of progression in people with prediabetes, but adherence is important.

The D2d (Vitamin D and type 2 diabetes) trial previously suggested that vitamin D supplementation might reduce the rate of progression from prediabetes to type 2 diabetes; however, observed differences in the intention-to-treat analyses did not reach significance (Pittas et al, 2019). The present secondary analysis of D2d data sought to examine the effects of vitamin D supplementation on prediabetes progression and regression on a per-protocol basis; that is, in those participants who adhered to the study treatment protocol and who were not prescribed diabetes/weight loss medications, which might have obscured some of the effects of the intervention.

The 2423 participants were randomised to receive 4000 IU of vitamin D or placebo once daily. Over a median follow-up of 2.5 years, the hazard ratio for progression to type 2 diabetes was 0.84 (95% CI, 0.71–0.99) in the vitamin D group. The intervention group was also more likely to achieve normal glucose regulation (defined as two or three of the following measures falling below the ADA thresholds for diabetes: fasting plasma glucose ≥7.0 mmol/L, 2-hour glucose ≥11.1 mmol/L or HbA1c ≥48 mmol/mol [6.5%]) than the placebo group (12.4% vs 9.5% of participants; rate ratio 1.31).

The authors conclude that among participants who were adherent to the D2d study protocol, vitamin D supplementation lowered the risk of developing type 2 diabetes and increased the likelihood of regression to normal glucose regulation.

Click here to read the study in full.

REFERENCES:

Pittas AG, Dawson-Hughes B, Sheehan P et al; D2d Research Group (2019) Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med 381: 520–30

Related content
;
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.